Literature DB >> 29566965

Predicting eventual development of lupus nephritis at the time of diagnosis of systemic lupus erythematosus.

Oh Chan Kwon1, Jung Sun Lee1, Byeongzu Ghang1, Yong-Gil Kim1, Chang-Keun Lee1, Bin Yoo1, Seokchan Hong2.   

Abstract

OBJECTIVES: To investigate factors predictive of future lupus nephritis development when systemic lupus erythematosus (SLE) is diagnosed.
METHODS: Patients with newly diagnosed SLE without renal manifestations were followed for development of lupus nephritis, comparing findings at baseline between those who did or did not develop nephritis. Albumin-to-globulin ratio (AGR) was calculated as albumin/(total protein-albumin). Cox proportional hazard model was used to identify predictors of lupus nephritis.
RESULTS: Of 278 patients, 241 did not and 37 did develop lupus nephritis during follow-up. On univariate analysis, young age, low C3, low C4, high anti-dsDNA titre, anti-Sm antibody, anti-RNP antibody and low AGR were associated with a higher risk of lupus nephritis. On multivariate analysis, factors predictive of nephritis were age [adjusted hazard ratio (aHR) 0.928, 95% confidence interval (CI): 0.895-0.961, p < 0.001], C3 (aHR 0.977, 95% CI: 0.966-0.989, p < 0.001), anti-dsDNA titre (aHR 1.004, 95% CI: 1.000-1.007, p = 0.026) and anti-Sm antibody (aHR 2.097, 95% CI: 1.040-4.229, p = 0.038). In particular, a low AGR (aHR 4.972, 95% CI: 2.394-10.326, p < 0.001) was strongly associated with an increased risk of future lupus nephritis development.
CONCLUSION: Young age, low C3, high anti-dsDNA titre and presence of anti-Sm antibody at diagnosis of SLE were associated with a risk of future lupus nephritis, but the hazard was greatest with a low AGR value, suggesting that a greater proportion of immunoglobulin relative to total protein is associated with the development of nephritis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Albumin-to-globulin ratio; Lupus nephritis; Systemic lupus erythematosus

Mesh:

Substances:

Year:  2018        PMID: 29566965     DOI: 10.1016/j.semarthrit.2018.02.012

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  6 in total

Review 1.  Lupus nephritis.

Authors:  Hans-Joachim Anders; Ramesh Saxena; Ming-Hui Zhao; Ioannis Parodis; Jane E Salmon; Chandra Mohan
Journal:  Nat Rev Dis Primers       Date:  2020-01-23       Impact factor: 52.329

Review 2.  Lupus nephritis: challenges and progress.

Authors:  Anne Davidson; Cynthia Aranow; Meggan Mackay
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

3.  Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus.

Authors:  Xianyong Yin; Kwangwoo Kim; Hiroyuki Suetsugu; So-Young Bang; Leilei Wen; Masaru Koido; Eunji Ha; Lu Liu; Yuma Sakamoto; Sungsin Jo; Rui-Xue Leng; Nao Otomo; Viktoryia Laurynenka; Young-Chang Kwon; Yujun Sheng; Nobuhiko Sugano; Mi Yeong Hwang; Weiran Li; Masaya Mukai; Kyungheon Yoon; Minglong Cai; Kazuyoshi Ishigaki; Won Tae Chung; He Huang; Daisuke Takahashi; Shin-Seok Lee; Mengwei Wang; Kohei Karino; Seung-Cheol Shim; Xiaodong Zheng; Tomoya Miyamura; Young Mo Kang; Dongqing Ye; Junichi Nakamura; Chang-Hee Suh; Yuanjia Tang; Goro Motomura; Yong-Beom Park; Huihua Ding; Takeshi Kuroda; Jung-Yoon Choe; Chengxu Li; Hiroaki Niiro; Youngho Park; Changbing Shen; Takeshi Miyamoto; Ga-Young Ahn; Wenmin Fei; Tsutomu Takeuchi; Jung-Min Shin; Keke Li; Yasushi Kawaguchi; Yeon-Kyung Lee; Yongfei Wang; Koichi Amano; Dae Jin Park; Wanling Yang; Yoshifumi Tada; Ken Yamaji; Masato Shimizu; Takashi Atsumi; Akari Suzuki; Takayuki Sumida; Yukinori Okada; Koichi Matsuda; Keitaro Matsuo; Yuta Kochi; Leah C Kottyan; Matthew T Weirauch; Sreeja Parameswaran; Shruti Eswar; Hanan Salim; Xiaoting Chen; Kazuhiko Yamamoto; John B Harley; Koichiro Ohmura; Tae-Hwan Kim; Sen Yang; Takuaki Yamamoto; Bong-Jo Kim; Nan Shen; Shiro Ikegawa; Hye-Soon Lee; Xuejun Zhang; Chikashi Terao; Yong Cui; Sang-Cheol Bae
Journal:  Ann Rheum Dis       Date:  2020-12-03       Impact factor: 19.103

4.  Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease.

Authors:  Dionysis S Nikolopoulos; Myrto Kostopoulou; Dimitrios T Boumpas; Antonis Fanouriakis; Antigoni Pieta; Sofia Flouda; Katerina Chavatza; Aggelos Banos; John Boletis; Pelagia Katsimbri
Journal:  Lupus Sci Med       Date:  2020-06

Review 5.  Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus.

Authors:  Haitao Yu; Yasuo Nagafuchi; Keishi Fujio
Journal:  Biomolecules       Date:  2021-06-22

6.  Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis.

Authors:  Oh Chan Kwon; Jung Hwan Park; Hyeong-Cheon Park; Seung Min Jung; Sang-Won Lee; Jason Jungsik Song; Yong-Beom Park; Min-Chan Park
Journal:  Arthritis Res Ther       Date:  2020-06-09       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.